Position in BNTX
as of Jun 30, 2026
· filed Aug 25, 2026
Position Value
$390,810
+$17,514 QoQ
Shares Held
4,200
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#162
of 283 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Groupe la Francaise holds $13,850,146 across 9 Biotechnology names. BNTX ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
84,072 | $11,158,876 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
80,273 | $1,079,671 | |
| 3 | TBPH |
Theravance Biopharma, Inc.
|
30,000 | $510,000 | |
| 4 | BNTX |
BioNTech SE
This page
|
4,200 | $390,810 | |
| 5 | MRNA |
Moderna, Inc.
|
5,053 | $353,861 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
553 | $344,817 | |
| 7 | RPRX |
Royalty Pharma plc
|
216 | $12,111 | |
| 8 | 256,497 | $0 |
All Filings in BNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,810 | 4,200 | Shares | Defined | 2026-08-25 | |
| 2026-03-31 | $373,296 | 4,200 | Shares | Defined | 2026-05-21 | |
| 2025-12-31 | $399,840 | 4,200 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $462,034 | 4,685 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $447,174 | 4,200 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $382,452 | 4,200 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $478,590 | 4,200 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||